Praxbind (idarucizumab) by Boehringer Ingelheim
January 2016
Praxbind (idarucizumab) by Boehringer Ingelheim Praxbind (idarucizumab) by Boehringer Ingelheim Praxbind (idarucizumab) by Boehringer Ingelheim A monoclonal antibody to reverse the anticoagulant effects of dabigatran....
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive